These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25024625)

  • 21. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
    Stapleton J; Wo JM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study.
    Calles-Escandón J; Koch KL; Hasler WL; Van Natta ML; Pasricha PJ; Tonascia J; Parkman HP; Hamilton F; Herman WH; Basina M; Buckingham B; Earle K; Kirkeby K; Hairston K; Bright T; Rothberg AE; Kraftson AT; Siraj ES; Subauste A; Lee LA; Abell TL; McCallum RW; Sarosiek I; Nguyen L; Fass R; Snape WJ; Vaughn IA; Miriel LA; Farrugia G;
    PLoS One; 2018; 13(4):e0194759. PubMed ID: 29652893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis.
    Patterson D; Abell T; Rothstein R; Koch K; Barnett J
    Am J Gastroenterol; 1999 May; 94(5):1230-4. PubMed ID: 10235199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Satiety testing in diabetic gastroparesis: Effects of insulin pump therapy with continuous glucose monitoring on upper gastrointestinal symptoms and gastric myoelectrical activity.
    Koch KL; Hasler WL; Van Natta M; Calles-Escandon J; Grover M; Pasricha PJ; Snape WJ; Parkman HP; Abell TL; McCallum RW; Nguyen LA; Sarosiek I; Farrugia G; Tonascia J; Lee L; Miriel L; Hamilton F;
    Neurogastroenterol Motil; 2020 Jan; 32(1):e13720. PubMed ID: 31574209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders.
    Pasricha PJ; Yates KP; Sarosiek I; McCallum RW; Abell TL; Koch KL; Nguyen LAB; Snape WJ; Hasler WL; Clarke JO; Dhalla S; Stein EM; Lee LA; Miriel LA; Van Natta ML; Grover M; Farrugia G; Tonascia J; Hamilton FA; Parkman HP;
    Gastroenterology; 2018 Jan; 154(1):65-76.e11. PubMed ID: 29111115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastric per-oral endoscopic myotomy with antropyloromyotomy in the treatment of refractory gastroparesis: clinical experience with follow-up and scintigraphic evaluation (with video).
    Gonzalez JM; Lestelle V; Benezech A; Cohen J; Vitton V; Grimaud JC; Barthet M
    Gastrointest Endosc; 2017 Jan; 85(1):132-139. PubMed ID: 27478028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nausea and vomiting in diabetic and idiopathic gastroparesis.
    Cherian D; Parkman HP
    Neurogastroenterol Motil; 2012 Mar; 24(3):217-22, e103. PubMed ID: 22118574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between duration or etiology of gastroparesis and clinical response after gastric per-oral endoscopic pyloromyotomy.
    Mekaroonkamol P; Patel V; Shah R; Li B; Luo H; Shen S; Chen H; Shahnavaz N; Dacha S; Keilin S; Willingham FF; Christie J; Cai Q
    Gastrointest Endosc; 2019 May; 89(5):969-976. PubMed ID: 30653937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial.
    Andrews CN; Woo M; Buresi M; Curley M; Gupta M; Tack J; Wilsack L; Nasser Y
    Neurogastroenterol Motil; 2021 Jan; 33(1):e13958. PubMed ID: 32743954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits of Prokinetics, Gastroparesis Diet, or Neuromodulators Alone or in Combination for Symptoms of Gastroparesis.
    Hasler WL; Lee AA; Moshiree B; Surjanhata BC; Rao S; Parkman HP; Nguyen LA; Sarosiek I; Wo JM; Schulman MI; McCallum RW; Kuo B
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):867-877.e12. PubMed ID: 37913936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis.
    Wang CP; Kao CH; Chen WK; Lo WY; Hsieh CL
    J Altern Complement Med; 2008 Sep; 14(7):833-9. PubMed ID: 18721079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mirtazapine for symptom control in refractory gastroparesis.
    Malamood M; Roberts A; Kataria R; Parkman HP; Schey R
    Drug Des Devel Ther; 2017; 11():1035-1041. PubMed ID: 28408802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bloating in gastroparesis: severity, impact, and associated factors.
    Hasler WL; Wilson LA; Parkman HP; Nguyen L; Abell TL; Koch KL; Pasricha PJ; Snape WJ; Farrugia G; Lee L; Tonascia J; Unalp-Arida A; Hamilton F;
    Am J Gastroenterol; 2011 Aug; 106(8):1492-502. PubMed ID: 21483459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data.
    Wo JM; Ejskjaer N; Hellström PM; Malik RA; Pezzullo JC; Shaughnessy L; Charlton P; Kosutic G; McCallum RW
    Aliment Pharmacol Ther; 2011 Mar; 33(6):679-88. PubMed ID: 21214610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastric Electric Stimulation for Refractory Gastroparesis: A Prospective Analysis of 151 Patients at a Single Center.
    Heckert J; Sankineni A; Hughes WB; Harbison S; Parkman H
    Dig Dis Sci; 2016 Jan; 61(1):168-75. PubMed ID: 26280084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buspirone for early satiety and symptoms of gastroparesis: A multi-centre, randomised, placebo-controlled, double-masked trial (BESST).
    Parkman HP; Yates KP; Sarosiek I; Bulat RS; Abell TL; Koch KL; Kuo B; Grover M; Farrugia G; Silver P; Abdullah A; Maurer AH; Malik Z; Miriel LA; Tonascia J; Hamilton F; Pasricha PJ; McCallum RW;
    Aliment Pharmacol Ther; 2023 Jun; 57(11):1272-1289. PubMed ID: 37052334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptoms from the Gastroparesis Cardinal Symptom Index and clinical factors associated with delayed gastric emptying in patients with suspected gastroparesis.
    Sabat C; Lebtahi R; Duboc H; Dior M; Coffin B; Soliman H
    Neurogastroenterol Motil; 2024 Aug; 36(8):e14821. PubMed ID: 38798079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility, safety, and long-term efficacy of gastric peroral endoscopic myotomy (G-POEM) for postsurgical gastroparesis: a single-center and retrospective study of a prospective database.
    Tan J; Shrestha SM; Wei M; Wang P; Shi J; Lu Y; Gao Q; Lu T; Zhou J; Shi R
    Surg Endosc; 2021 Jul; 35(7):3459-3470. PubMed ID: 32880749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic gastroparesis.
    Koch KL; Calles-Escandón J
    Gastroenterol Clin North Am; 2015 Mar; 44(1):39-57. PubMed ID: 25667022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy.
    Cassilly DW; Wang YR; Friedenberg FK; Nelson DB; Maurer AH; Parkman HP
    Digestion; 2008; 78(2-3):144-51. PubMed ID: 19033686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.